Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome

Background  Although photodynamic therapy (PDT) is becoming an important treatment method for skin lesions such as actinic keratosis (AK) and superficial basal cell carcinoma, there are still discussions about which fluence rate and light dose are preferable. Recent studies in rodents have shown that a low fluence rate is preferable due to depletion of oxygen at high fluence rates. However, these results have not yet been verified in humans.

[1]  T. Hasan,et al.  In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. , 1999, Cancer research.

[2]  S. Iinuma,et al.  A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.

[3]  J Moan,et al.  Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light. , 2001, Journal of photochemistry and photobiology. B, Biology.

[4]  T. Foster,et al.  Singlet Oxygen‐Versus Nonsinglet Oxygen‐Mediated Mechanisms of Sensitizer Photobleaching and Their Effects on Photodynamic Dosimetry , 1998, Photochemistry and photobiology.

[5]  M. Ericson,et al.  Pain caused by photodynamic therapy of skin cancer , 2002, Clinical and experimental dermatology.

[6]  Christopher S. Foote,et al.  Mechanisms of Photosensitized Oxidation , 1968 .

[7]  J Moan,et al.  Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer Research.

[8]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[9]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[10]  K. Mardia,et al.  A review of image-warping methods , 1998 .

[11]  J. Nelson,et al.  Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. , 1997, Archives of dermatology.

[12]  Willem M. Star,et al.  Protoporphyrin IX Fluorescence Kinetics and Localization after Topical Application of ALA Pentyl Ester and ALA on Hairless Mouse Skin with UVB-Induced Early Skin Cancer , 2000, Photochemistry and photobiology.

[13]  M G Nichols,et al.  Fluence rate effects in photodynamic therapy of multicell tumor spheroids. , 1993, Cancer research.

[14]  B. Henderson,et al.  The Effect of Fluence Rate on Tumor and Normal Tissue Responses to Photodynamic Therapy , 1998, Photochemistry and photobiology.

[15]  W Sibbett,et al.  The Application of a Compact Multispectral Imaging System with Integrated Excitation Source to In vivo Monitoring of Fluorescence During Topical Photodynamic Therapy of Superficial Skin Cancers ¶ , 2001, Photochemistry and photobiology.

[16]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[17]  Y. Garini,et al.  Fourier Transform Multipixel Spectroscopy and Spectral Imaging of Protoporphyrin in Single Melanoma Cells , 1996, Photochemistry and photobiology.

[18]  C. Foote.  Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. , 1968, Science.

[19]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[20]  Erik Nielsen,et al.  Statistics for analytical chemistry , 1987 .

[21]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[22]  J Moan,et al.  Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinoma , 1992, International journal of cancer.

[23]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[24]  D. Whitten,et al.  Mechanisms for the photooxidation of protoporphyrin IX in solution , 1982 .

[25]  E. Hull,et al.  Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.

[26]  J Moan,et al.  Phototransformations of 5-Aminolevulinic Acid–induced Protoporphyrin IX in vitro: A Spectroscopic Study¶ , 2000, Photochemistry and photobiology.

[27]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[28]  R. M. Szeimiesa,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .

[29]  Stanley B. Brown,et al.  Protoporphyrin IX Fluorescence Photobleaching during ALA‐Mediated Photodynamic Therapy of UVB‐Induced Tumors in Hairless Mouse Skin , 1999, Photochemistry and photobiology.

[30]  H. Inhoffen,et al.  Zur weiteren Kenntnis des Chlorophylls und des Hämins, XXX1) Photoprotoporphyrine und ihre Umwandlung in Spirographis- sowie Isospirographis-porphyrin2) , 1969 .

[31]  B. Tromberg,et al.  In vivo TUMOR OXYGEN TENSION MEASUREMENTS FOR THE EVALUATION OF THE EFFICIENCY OF PHOTODYNAMIC THERAPY , 1990, Photochemistry and photobiology.

[32]  M. Alpsten,et al.  Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp , 1996, Archives of Dermatological Research.

[33]  H Moseley,et al.  Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group , 2002, The British journal of dermatology.

[34]  D. Salomon,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002, Journal of the American Academy of Dermatology.

[35]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[36]  Q. Peng,et al.  5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. , 1997, Cancer.

[37]  CLAUDE C. FRAZIER,et al.  PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.

[38]  G. Themelis,et al.  In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. , 2000, European journal of dermatology : EJD.

[39]  M. Landthaler,et al.  Long‐pulse dye laser for photodynamic therapy: Investigations in vitro and in vivo , 1999, Lasers in surgery and medicine.

[40]  H Kerl,et al.  Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. , 1997, Journal of photochemistry and photobiology. B, Biology.

[41]  B. Henderson,et al.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. , 1998, British Journal of Cancer.

[42]  T. Mukherjee,et al.  Triplet excited states and semiquinone radicals of 1,4-disubstituted anthraquinones , 1990 .

[43]  J. Moan,et al.  A spectroscopic study of the photobleaching of protoporphyrin IX in solution , 2003, Lasers in Medical Science.

[44]  K König,et al.  In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. , 1993, Journal of photochemistry and photobiology. B, Biology.